{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:27:29Z","timestamp":1761611249972},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T00:00:00Z","timestamp":1249948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s11239-009-0382-7","type":"journal-article","created":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T04:41:33Z","timestamp":1249879293000},"page":"483-488","source":"Crossref","is-referenced-by-count":12,"title":["Comparative effects of cilostazol and aspirin on the impairment of endothelium-dependent cerebral vasodilation caused by acute cigarette smoking in rats"],"prefix":"10.1007","volume":"29","author":[{"given":"Hiroki","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyasu","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokazu","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"key":"382_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.1988.03720070025028","volume":"259","author":"PA Wolf","year":"1988","unstructured":"Wolf PA, D\u2019Agostino RB, Kannel WB et al (1988) Cigarette smoking as a risk factor for stroke. The Framingham Study. Jama 259:1025\u20131029","journal-title":"Jama"},{"key":"382_CR2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.STR.0000128794.30660.e8","volume":"35","author":"T Mannami","year":"2004","unstructured":"Mannami T, Iso H, Baba S et al (2004) Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC study cohort I. Stroke 35:1248\u20131253","journal-title":"Stroke"},{"key":"382_CR3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000091224","volume":"21","author":"B Ovbiagele","year":"2006","unstructured":"Ovbiagele B, Weir CJ, Saver JL et al (2006) Effect of smoking status on outcome after acute ischemic stroke. Cerebrovasc Dis 21:260\u2013265","journal-title":"Cerebrovasc Dis"},{"key":"382_CR4","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","volume":"88","author":"DS Celermajer","year":"1993","unstructured":"Celermajer DS, Sorensen KE, Georgakopoulos D et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149\u20132155","journal-title":"Circulation"},{"key":"382_CR5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/01.CIR.93.7.1346","volume":"93","author":"T Heitzer","year":"1996","unstructured":"Heitzer T, Yla-Herttuala S, Luoma J et al (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93:1346\u20131353","journal-title":"Circulation"},{"key":"382_CR6","doi-asserted-by":"crossref","first-page":"H528","DOI":"10.1152\/ajpheart.00752.2002","volume":"284","author":"Q Fang","year":"2003","unstructured":"Fang Q, Sun H, Mayhan WG (2003) Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 284:H528\u2013H534","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"382_CR7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.lfs.2005.07.004","volume":"78","author":"H Iida","year":"2006","unstructured":"Iida H, Iida M, Takenaka M et al (2006) Angiotensin II type 1 (AT1)-receptor blocker prevents impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats. Life Sci 78:1310\u20131316","journal-title":"Life Sci"},{"key":"382_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3317\/jraas.2008.012","volume":"9","author":"H Iida","year":"2008","unstructured":"Iida H, Iida M, Takenaka M et al (2008) Rho-kinase inhibitor and nicotinamide adenine dinucleotide phosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats. J Renin Angiotensin Aldosterone Syst 9:89\u201394","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"382_CR9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.106.653741","volume":"115","author":"JK Liao","year":"2007","unstructured":"Liao JK (2007) Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation 115:1615\u20131621","journal-title":"Circulation"},{"key":"382_CR10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(08)70094-2","volume":"7","author":"Y Huang","year":"2008","unstructured":"Huang Y, Cheng Y, Wu J et al (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomized, double-blind, pilot study. Lancet Neurol 7:494\u2013499","journal-title":"Lancet Neurol"},{"key":"382_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5551\/jat.10.93","volume":"10","author":"K Oida","year":"2003","unstructured":"Oida K, Ebata K, Kanehara H et al (2003) Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokers. J Atheroscler Thromb 10:93\u201398","journal-title":"J Atheroscler Thromb"},{"key":"382_CR12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2006.01.022","volume":"189","author":"A Hashimoto","year":"2006","unstructured":"Hashimoto A, Miyakoda G, Hirose Y, Mori T (2006) Activation of endothelial nitric oxide synthase by cilostazol via a cAMP\/protein kinase A- and phosphatidylinositol 3-kinase\/Akt-dependent mechanism. Atherosclerosis 189:350\u2013357","journal-title":"Atherosclerosis"},{"key":"382_CR13","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/jpet.105.098509","volume":"317","author":"SY Park","year":"2006","unstructured":"Park SY, Lee JH, Kim CD et al (2006) Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. J Pharmacol Exp Ther 317:1238\u20131245","journal-title":"J Pharmacol Exp Ther"},{"key":"382_CR14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.shk.0000228800.56223.db","volume":"26","author":"T Iba","year":"2006","unstructured":"Iba T, Kidokoro A, Fukunaga M et al (2006) Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock 26:522\u2013526","journal-title":"Shock"},{"key":"382_CR15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0008-6363(98)00013-3","volume":"38","author":"JP Noon","year":"1998","unstructured":"Noon JP, Walker BR, Hand MF, Webb DJ (1998) Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res 38:480\u2013484","journal-title":"Cardiovasc Res"},{"key":"382_CR16","first-page":"1633","volume":"25","author":"S Deng","year":"2004","unstructured":"Deng S, Deng PY, Jiang JL et al (2004) Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Acta Pharmacol Sin 25:1633\u20131639","journal-title":"Acta Pharmacol Sin"},{"key":"382_CR17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.lfs.2008.01.017","volume":"82","author":"T Ishizuka","year":"2008","unstructured":"Ishizuka T, Niwa A, Tabuchi M et al (2008) Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats. Life Sci 82:806\u2013815","journal-title":"Life Sci"},{"key":"382_CR18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.STR.29.8.1656","volume":"29","author":"M Iida","year":"1998","unstructured":"Iida M, Iida H, Dohi S et al (1998) Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo. Stroke 29:1656\u20131665","journal-title":"Stroke"},{"key":"382_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosissup.2005.09.003","volume":"6","author":"M Matsumoto","year":"2005","unstructured":"Matsumoto M (2005) Cilostazol in secondary prevention of stroke: impact of the cilostazol stroke prevention study. Atheroscler Suppl 6:33\u201340","journal-title":"Atheroscler Suppl"},{"key":"382_CR20","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0024-3205(01)01258-9","volume":"69","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Houchi H, Minami A et al (2001) Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sci 69:1709\u20131715","journal-title":"Life Sci"},{"key":"382_CR21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09537100410001715583","volume":"15","author":"H Ito","year":"2004","unstructured":"Ito H, Miyakoda G, Mori T (2004) Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Platelets 15:293\u2013301","journal-title":"Platelets"},{"key":"382_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0049-3848(03)00419-5","volume":"110","author":"M Madajka","year":"2003","unstructured":"Madajka M, Korda M, White J, Malinski T (2003) Effect of aspirin on constitutive nitric oxide synthase and the biovailability of NO. Thromb Res 110:317\u2013321","journal-title":"Thromb Res"},{"key":"382_CR23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1160\/TH06-10-0555","volume":"97","author":"P Gresele","year":"2007","unstructured":"Gresele P, Migliacci R, Procacci A et al (2007) Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Thromb Haemost 97:444\u2013450","journal-title":"Thromb Haemost"},{"key":"382_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9149(03)00458-2","volume":"92","author":"K Watanabe","year":"2003","unstructured":"Watanabe K, Ikeda S, Komatsu J et al (2003) Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris. Am J Cardiol 92:21\u201325","journal-title":"Am J Cardiol"},{"key":"382_CR25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1076\/apab.111.3.232.23454","volume":"111","author":"I Bilgen","year":"2003","unstructured":"Bilgen I, Oner G, Eren E (2003) Dietary l-arginine restores aspirin-induced endothelial dysfunction in rat aorta. Arch Physiol Biochem 111:232\u2013238","journal-title":"Arch Physiol Biochem"},{"key":"382_CR26","first-page":"1124","volume":"35","author":"H Akiyama","year":"1985","unstructured":"Akiyama H, Kudo S, Shimizu T (1985) The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. Arzneimittelforschung 35:1124\u20131132","journal-title":"Arzneimittelforschung"},{"key":"382_CR27","first-page":"1133","volume":"35","author":"H Akiyama","year":"1985","unstructured":"Akiyama H, Kudo S, Shimizu T (1985) The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man. Arzneimittelforschung 35:1133\u20131140","journal-title":"Arzneimittelforschung"},{"key":"382_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/jpet.109.151548","volume":"330","author":"Y Nonaka","year":"2009","unstructured":"Nonaka Y, Koumura A, Hyakkoku K et al (2009) Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone. J Pharmacol Exp Ther 330:13\u201322","journal-title":"J Pharmacol Exp Ther"},{"key":"382_CR29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.300.3.787","volume":"300","author":"JM Choi","year":"2002","unstructured":"Choi JM, Shin HK, Kim KY et al (2002) Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 300:787\u2013793","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-009-0382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-009-0382-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-009-0382-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:43Z","timestamp":1559386903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-009-0382-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s11239-009-0382-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]}}}